Friday, May 16, 2008

[StemCells] Off-the-shelf bone graft

NuVasive Acquires First Stem Cell Bone Graft Substitute


New technologies will drive US bone graft substitute market to reach
almost
$1.9 billion by 2012, according to Millennium Research Group

WALTHAM, Mass., May 14 /PRNewswire/ -- With the acquisition of
Osiris
Therapeutics' Osteocel business, NuVasive has obtained the first
off-the-shelf bone graft substitute (BGS) product to incorporate
viable
stem cells. Mounting surgeon excitement about this new BGS and other
innovative products will drive the BGS market to $1.9 billion in 2012,
according to Millennium Research Group's US Markets for Orthopedic
Biomaterials 2008 report.

"The popularity of advanced BGS technologies has increased
competition
within the field. Medtronic Spinal and Biologics' INFUSE BGS, based
on a
recombinant human bone morphogenetic protein, has forced NuVasive and
other
BGS competitors to dramatically innovate," says Kevin Flewwelling,
Orthopedics Research Manager at Millennium Research Group. "In 2007,
INFUSE
sales exceeded $700 million in the US and NuVasive saw an opportunity
to
compete against this very successful product."

In order to compete against these advanced BGS, other
manufacturers of
traditional BGS products -- such as demineralized bone matrices and
synthetics -- are developing next-generation products that offer
improved
ease-of-use and superior bone healing and regrowth. Companies claim
that
these new features eliminate the need for autograft bone harvested
from the
patient's iliac crest, reducing postoperative pain and morbidity at
the
donor site. With these greater advantages, surgeons are shifting
towards
these newer devices. A survey of surgeons conducted by Millennium
Research
Group found that 30.3% expected to perform fewer procedures using only
autograft bone by 2012.

In addition to the BGS market, the US Markets for Orthopedic
Biomaterials 2008 report covers the hyaluronic acid
viscosupplementation,
machined bone interbody device, knee cartilage repair, and cell
concentration system markets. The report also provides coverage of
all key
industry competitors, including AlloSource, Biomet, Blackstone
Medical/Orthofix, DePuy, Exactech, Ferring Pharmaceuticals, Genzyme
Biosurgery, Integra LifeSciences/IsoTis, LifeNet Health, Medtronic
Spinal
and Biologics, Musculoskeletal Transplant Foundation, Orthovita,
Osiris
Therapeutics, Osteotech, RTI Biologics, sanofi-aventis, Smith &
Nephew,
Stryker, Synthes, and Wright Medical Technology. Other reports in this
series cover Europe (France, Germany, Italy, Spain, and the UK) and
Japan.

About Bone Graft Substitutes

BGS are classified under the broader term of bone grafts. Bone
grafts
are used to promote bone healing and regrowth and fill bone voids in
spinal
fusion, trauma surgery, joint revision and reconstruction, and
craniomaxillofacial surgery. These products can be classified into six
categories: autograft, nonproprietary allograft, demineralized bone
matrix,
synthetics, growth factors -- such as bone morphogenetic proteins --
and
stem cell products. Autograft is the only bone graft material that is
taken
from a patient's own body. Other bone graft materials are commonly
referred
to as BGS.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision
Resources, Inc.
company (http://www.DecisionResources.com), is the global authority
on medical
technology market intelligence and a leading provider of strategic
information to the health care sector. Focused solely on the medical
device, pharmaceutical, and biotechnology industries, the company
provides
its clients with the benefits of its specialized industry expertise
through
published reports and customized consulting services.

All company, brand, or product names contained in this document
may be
trademarks or registered trademarks of their respective holders.

For more information, contact:
Amy Krohn
Millennium Research Group
416-364-7776 x101
akrohn@mrg.net

http://www.prnewswire.com/cgi-bin/stories.pl?
ACCT=104&STORY=/www/story/05-14-2008/0004813295&EDATE=


__._,_.___
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:

Children's Neurobiological Solutions
http://www.CNSfoundation.org/

Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123

The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Recent Activity
Visit Your Group
Yahoo! News

Get it all here

Breaking news to

entertainment news

Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Find Balance

on Yahoo! Groups

manage nutrition,

activity & well-being.

.

__,_._,___

No comments:



about stem cell research
adult stem cell
adult stem cell research
adult stem cells
against stem cell
against stem cell research
anti stem cell
anti stem cell research
autologous stem cell
autologous stem cell transplant
benefits of stem cell research
blood stem cells
bone marrow stem cells
bush stem cell
california stem cell
cancer stem cell
cancer stem cells
cell stem cell
cons of stem cell research
cord blood stem cell
cord blood stem cells
cord stem cells
diabetes stem cell
embryonic stem cell
embryonic stem cell research
embryonic stem cells
for stem cell research
funding for stem cell research
harvard stem cell
harvard stem cell institute
hematopoietic stem cell
hematopoietic stem cells
history of stem cell research
human embryonic stem cell
human embryonic stem cell research
human embryonic stem cells
international stem cell
mesenchymal stem cell
mesenchymal stem cells
neural stem cell
neural stem cells
nih stem cell
pluripotent stem cells
pro stem cell
pro stem cell research
pros and cons of stem cell
pros and cons of stem cell research
stem cell
stem cell bank
stem cell bill
stem cell biology
stem cell companies
stem cell conference
stem cell controversy
stem cell cures
stem cell debate
stem cell differentiation
stem cell ethics
stem cell funding
stem cell heart
stem cell information
stem cell institute
stem cell line
stem cell lines
stem cell news
stem cell policy
stem cell reasearch
stem cell reaserch
stem cell reseach
stem cell research
stem cell research articles
stem cell research bill
stem cell research controversy
stem cell research debate
stem cell research enhancement act
stem cell research ethics
stem cell research facts
stem cell research funding
stem cell research pros
stem cell research pros and cons
stem cell reserach
stem cell reserch
stem cell technologies
stem cell technology
stem cell therapy
stem cell transplant
stem cell transplantation
stem cell transplants
stem cell treatment
stem cell treatments
stem cell veto
stem cells
stem cells research
support stem cell research
types of stem cells
umbilical cord stem cells
what are stem cells
what is a stem cell
what is stem cell
what is stem cell research